Newton biotech’s drug for hot flashes due to menopause fails trial

Shares of the company plummeted 40% after the results of a midstage clinical trial were announced.

Previous Lab Notes: Eagles Autism Foundation distributes $4.1 million to support 20 autism-focused projects
Next Cobb Galleria Centre's new chef: 'Atlanta's food scene has come a long way'